Immune checkpoint inhibitor-induced vitiligo in advanced melanoma could be related to increased levels of CCL19

T. Fujimura, K. Tanita, Y. Sato, C. Lyu, Y. Kambayashi, Y. Fujisawa, H. Uchi, Y. Yamamoto, A. Otsuka, K. Yoshino, S. Matsushita, T. Funakoshi, S. Fukushima, H. Hata, A. Hashimoto, S. Aiba

Research output: Contribution to journalLetter

Original languageEnglish
JournalBritish Journal of Dermatology
DOIs
Publication statusAccepted/In press - 2019 Jan 1

ASJC Scopus subject areas

  • Dermatology

Cite this

Fujimura, T., Tanita, K., Sato, Y., Lyu, C., Kambayashi, Y., Fujisawa, Y., Uchi, H., Yamamoto, Y., Otsuka, A., Yoshino, K., Matsushita, S., Funakoshi, T., Fukushima, S., Hata, H., Hashimoto, A., & Aiba, S. (Accepted/In press). Immune checkpoint inhibitor-induced vitiligo in advanced melanoma could be related to increased levels of CCL19. British Journal of Dermatology. https://doi.org/10.1111/bjd.18721